| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On December 5, 2003
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1981N-0033P
|
| Antiplaque & Antiplaque-Related Claims
|
|
|
|
|
| 2002N-0278
|
| Bioterrorism; Prior Notice of Imported Food Shipments
|
|
|
|
|
| 2003D-0385
|
| Guidance for Industry: Comparability Protocols - Protein Drug Products and Biologic Products - Chemistry, Manufacturing, and Controls Information
|
|
|
|
|
| 2003E-0261
|
| Patent Extension for Strattera (atomoxetine hydrochloride), 5,658,590
|
|
|
|
|
| 2003N-0106
|
| Using FDA forms 3503/3504 submissions Petitions,Food/color
|
|
|
|
|
| 2003N-0338
|
| Obesity
|
|
|
|
|
| 2003P-0479
|
| Allow importation of Canadian versions of drugs that are approved to the United States
|
|
|
|
|
| 2003P-0530
|
| Silicone Gel-filled Breast Implants
|
|
|
|
|
| 1981N-0033P
|
| Antiplaque & Antiplaque-Related Claims
|
|
|
|
|
| C
21
|
| American Dental Association (ADA)
|
| Vol #:
|
| 86
|
|
|
|
|
| SUP
3
|
| WhiteHill Oral Technologies, Inc.
|
| Vol #:
|
| 86
|
|
|
|
|
| 2002N-0278
|
| Bioterrorism; Prior Notice of Imported Food Shipments
|
|
|
|
|
| C
236
|
| E & B International, Inc
|
| Vol #:
|
| 17
|
|
|
|
|
| EC 329
|
| Lang, Florian
|
| Vol #:
|
| 17
|
|
|
|
|
| EC 330
|
| Rish, David
|
| Vol #:
|
| 17
|
|
|
|
|
| EC 332
|
| Powell, Susan
|
| Vol #:
|
| 17
|
|
|
|
|
| EC 334
|
| Parker, Glen
|
| Vol #:
|
| 17
|
|
|
|
|
| EMC 127
|
| J M Rice
|
| Vol #:
|
| 17
|
|
|
|
|
| 2003D-0385
|
| Guidance for Industry: Comparability Protocols - Protein Drug Products and Biologic Products - Chemistry, Manufacturing, and Controls Information
|
|
|
|
|
| C
3
|
| PDA
|
| Vol #:
|
| 1
|
|
|
|
|
| C
4
|
| Aventis Pasteur
|
| Vol #:
|
| 1
|
|
|
|
|
| C
5
|
| Centocor Inc
|
| Vol #:
|
| 1
|
|
|
|
|
| C
6
|
| Genentech, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 2
|
| Whisler, Mary Faye
|
| Vol #:
|
| 1
|
|
|
|
|
| EMC
2
|
| Merck & Co., Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| EMC
3
|
| Biotechnology Industry Organization (BIO)
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003E-0261
|
| Patent Extension for Strattera (atomoxetine hydrochloride), 5,658,590
|
|
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003N-0106
|
| Using FDA forms 3503/3504 submissions Petitions,Food/color
|
|
|
|
|
| NAL
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| SS
1
|
| Supporting Statement
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003N-0338
|
| Obesity
|
|
